This content is machine translated Dyslipidemia: "Treat-to-target" Risk-adapted individual LDL-C targets Together with arterial hypertension and diabetes mellitus, lipid metabolism disorders are among the most important modifiable cardiovascular risk factors. In addition to statins, various modern substance classes are now available...…
View Post 6 min This content is machine translated Atopic dermatitis: "Treat-to-target" Current secondary analyses expand the evidence base In the recent past, several secondary analyses have been published in which different treatment regimes for atopic dermatitis (AD) were compared and evaluated. In order to evaluate treatment progress using…
View Post 5 min This content is machine translated Rheumatoid arthritis Using predictors to improve therapy management A few years ago, the EULAR agreed on a definition for “difficult-to-treat” rheumatoid arthritis (RA).The reasons for multiple treatment failures are not yet fully understood. Research projects are trying to…
View Post 5 min This content is machine translated Polymyalgia rheumatica and giant cell arteritis New consensus paper recommends “treat-to-target” strategy Giant cell arteritis and polymyalgia rheumatica are inflammatory rheumatic diseases that often occur together and almost exclusively affect people over the age of 50. Glucocorticoids are initially used for both…
View Post 4 min This content is machine translated Systemic lupus erythematosus Protection against relapses, even without remission The line between low disease activity and remission in systemic lupus erythematosus is often imprecise. The question remains to what extent this can play a role for outcomes such as…
View Post 6 min This content is machine translated Chronic urticaria “Treat-to-target” approach is underpinned by new findings The treatment arsenal for chronic urticaria includes several 2nd generation antihistamines – still the treatment of first choice – the monoclonal antibody Omalizumab and the immunosuppressant Ciclosporin A as an…
View Post 8 min This content is machine translated "Treat-to-Target" or "High Intensity". Which statin strategy is better? Titrated individually according to LDL target value (“Treat to Target”) or uniformly high doses for all patients (“High Intensity”)? Which of the two strategies is clinically better in the case…
View Post 5 min This content is machine translated Rheumatoid arthritis How do current research findings influence future RA therapy? Three renowned experts in the field of rheumatoid arthritis, Prof. Edward Keystone, MD, Toronto, Prof. Ronald van Vollenhoven, MD, Stockholm, and Prof. Peter Taylor, MD, Oxford, gave an overview of…
